Sensus Healthcare, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Sensus Healthcare, Inc. (SRTS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.40% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2023-03-23
- Sensus Healthcare, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.40%, a 500.00% decline from fiscal 2021.
- Sensus Healthcare, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2022-12-31 | -0.40% 10-K · filed 2023-03-23 |
| 2021-12-31 | 0.10% 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |